Allscripts (MDRX) Misses Q1 EPS by 6c, Revenues Miss; Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Allscripts Announces First Quarter 2020 Results
May 7, 2020 4:01 PM EDTFirst quarter 2020 bookings of $205 million, above high end of outlook range
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2020.
Bookings(1) were $205 million in the first quarter of 2020. This result compares with $286 million in the first quarter of 2019. Contract revenue backlog totaled $4.5 billion as of March 31, 2020.
First quarter 2020 revenue was $417 million compared with $432 million in the first quarter of 2019.
On a GAAP basis in the first quarter of 2020 total operating expenses were $166... More
